USPP20149P2 - New and distinct somaclonal variety of rose scented geranium - Google Patents
New and distinct somaclonal variety of rose scented geranium Download PDFInfo
- Publication number
- USPP20149P2 USPP20149P2 US09/539,992 US53999200V USPP20149P2 US PP20149 P2 USPP20149 P2 US PP20149P2 US 53999200 V US53999200 V US 53999200V US PP20149 P2 USPP20149 P2 US PP20149P2
- Authority
- US
- United States
- Prior art keywords
- parimal
- oil
- somaclone
- map
- geranium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001138371 Pelargonium capitatum Species 0.000 title claims abstract description 12
- 244000270673 Pelargonium graveolens Species 0.000 abstract description 8
- 235000017927 Pelargonium graveolens Nutrition 0.000 abstract description 6
- 239000003921 oil Substances 0.000 description 32
- 235000019198 oils Nutrition 0.000 description 32
- 241000196324 Embryophyta Species 0.000 description 21
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 16
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 16
- 239000000341 volatile oil Substances 0.000 description 11
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 10
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 8
- 239000005792 Geraniol Substances 0.000 description 8
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 8
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 8
- 235000000484 citronellol Nutrition 0.000 description 8
- 229940113087 geraniol Drugs 0.000 description 8
- 230000000877 morphologic effect Effects 0.000 description 8
- 241000208152 Geranium Species 0.000 description 7
- 239000010648 geranium oil Substances 0.000 description 7
- DZNVIZQPWLDQHI-UHFFFAOYSA-N Citronellyl formate Chemical compound O=COCCC(C)CCC=C(C)C DZNVIZQPWLDQHI-UHFFFAOYSA-N 0.000 description 6
- 235000019717 geranium oil Nutrition 0.000 description 6
- 150000003505 terpenes Chemical class 0.000 description 6
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 5
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 5
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 5
- 229930007744 linalool Natural products 0.000 description 5
- 238000003892 spreading Methods 0.000 description 5
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000007480 spreading Effects 0.000 description 4
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N trans-Rosenoxid Natural products CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 4
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 4
- RCMUGHFHXFHKNW-UHFFFAOYSA-N (+)-guaia-6,9-diene Natural products CC1=CCC(C(C)C)=CC2C(C)CCC21 RCMUGHFHXFHKNW-UHFFFAOYSA-N 0.000 description 3
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 3
- IFJYSOWCCJPUJS-UHFFFAOYSA-N 1,4-dimethyl-7-propan-2-yl-1,2,3,4,5,8-hexahydroazulene Chemical compound C1C(C(C)C)=CCC(C)C2=C1C(C)CC2 IFJYSOWCCJPUJS-UHFFFAOYSA-N 0.000 description 3
- VVUMWAHNKOLVSN-UHFFFAOYSA-N 2-(4-ethoxyanilino)-n-propylpropanamide Chemical compound CCCNC(=O)C(C)NC1=CC=C(OCC)C=C1 VVUMWAHNKOLVSN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- 241000335574 Narayana Species 0.000 description 3
- 241000208181 Pelargonium Species 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- FQMZVFJYMPNUCT-UHFFFAOYSA-N geraniol formate Natural products CC(C)=CCCC(C)=CCOC=O FQMZVFJYMPNUCT-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 2
- CZCBTSFUTPZVKJ-ZJUUUORDSA-N (2R,4R)-rose oxide Chemical compound C[C@@H]1CCO[C@@H](C=C(C)C)C1 CZCBTSFUTPZVKJ-ZJUUUORDSA-N 0.000 description 2
- WMOPMQRJLLIEJV-DOMZBBRYSA-N 10-epi-eudesm-4-en-11-ol Chemical compound C1[C@H](C(C)(C)O)CC[C@]2(C)CCCC(C)=C21 WMOPMQRJLLIEJV-DOMZBBRYSA-N 0.000 description 2
- IYYUJCKJSSPXQQ-UHFFFAOYSA-N 2-pyridin-4-yl-1,3-thiazolidin-3-ium-4-carboxylate Chemical compound N1C(C(=O)O)CSC1C1=CC=NC=C1 IYYUJCKJSSPXQQ-UHFFFAOYSA-N 0.000 description 2
- UCFQYMKLDPWFHZ-MKMNVTDBSA-N 3,7-dimethyloct-6-enyl (e)-2-methylbut-2-enoate Chemical compound C\C=C(/C)C(=O)OCCC(C)CCC=C(C)C UCFQYMKLDPWFHZ-MKMNVTDBSA-N 0.000 description 2
- WZKNLUWTEBWEOX-UHFFFAOYSA-N 6-[3-(pyridin-2-ylmethyl)pyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine Chemical compound N1=C2C(N)=NC=NC2=CC=C1N(C1)CCC1CC1=CC=CC=N1 WZKNLUWTEBWEOX-UHFFFAOYSA-N 0.000 description 2
- BIDUTRWDQRUKTQ-UHFFFAOYSA-N CC1CNNC1C1CCCN(C1)c1ccc2ncnc(N)c2n1 Chemical compound CC1CNNC1C1CCCN(C1)c1ccc2ncnc(N)c2n1 BIDUTRWDQRUKTQ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 2
- 241000208150 Geraniaceae Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
- 229960001669 kinetin Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229930007503 menthone Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- JFSSJJOGTVVJJC-UHFFFAOYSA-N 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2-carbonitrile Chemical compound CC1=CC(C)=C2C(N)=C(C#N)SC2=N1 JFSSJJOGTVVJJC-UHFFFAOYSA-N 0.000 description 1
- HXIPOURWZRATPT-UHFFFAOYSA-N 4-methyl-8-[4-(4-methylpiperazin-1-yl)phenyl]-2-(1-methylpyrazol-4-yl)-5h-pyrido[4,5]pyrrolo[1,2-d]pyrimidine Chemical compound C1CN(C)CCN1C1=CC=C(C=2C=C3C4=NC(=NC(C)=C4NC3=NC=2)C2=CN(C)N=C2)C=C1 HXIPOURWZRATPT-UHFFFAOYSA-N 0.000 description 1
- WMOPMQRJLLIEJV-UHFFFAOYSA-N 7-epi-gamma-eudesmanol Natural products C1C(C(C)(C)O)CCC2(C)CCCC(C)=C21 WMOPMQRJLLIEJV-UHFFFAOYSA-N 0.000 description 1
- YPHMUNZTHAUROX-UHFFFAOYSA-N CNC(=O)c1ccc2-c3sc(cc3CCOc2c1)-c1ccnn1-c1ccc(F)cc1F Chemical compound CNC(=O)c1ccc2-c3sc(cc3CCOc2c1)-c1ccnn1-c1ccc(F)cc1F YPHMUNZTHAUROX-UHFFFAOYSA-N 0.000 description 1
- IRMYZDGTYUUDIV-UHFFFAOYSA-N COc1cc(ccc1O)-c1cnc(Nc2ccc(cc2)N2CCN(C)CC2)c2nccn12 Chemical compound COc1cc(ccc1O)-c1cnc(Nc2ccc(cc2)N2CCN(C)CC2)c2nccn12 IRMYZDGTYUUDIV-UHFFFAOYSA-N 0.000 description 1
- BRLVLXDGOVHMTC-UHFFFAOYSA-N Clc1ccccc1-c1cc2cc(NC(=O)C3CC3)ncc2[nH]1 Chemical compound Clc1ccccc1-c1cc2cc(NC(=O)C3CC3)ncc2[nH]1 BRLVLXDGOVHMTC-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- LBDRYAKCYJHZHD-UHFFFAOYSA-N FC(F)(F)Cn1c(cc2cc(NC(=O)C3CC3)ncc12)-c1ccccc1Cl Chemical compound FC(F)(F)Cn1c(cc2cc(NC(=O)C3CC3)ncc12)-c1ccccc1Cl LBDRYAKCYJHZHD-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101000578823 Homo sapiens Microtubule-associated protein 10 Proteins 0.000 description 1
- 101000851850 Homo sapiens Trafficking protein particle complex subunit 14 Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 102100028380 Microtubule-associated protein 10 Human genes 0.000 description 1
- PBJMYYWFAJGFCX-UHFFFAOYSA-N N#Cc1cccc(c1)-c1cc2c(Nc3ccncc3)ncnn2c1 Chemical compound N#Cc1cccc(c1)-c1cc2c(Nc3ccncc3)ncnn2c1 PBJMYYWFAJGFCX-UHFFFAOYSA-N 0.000 description 1
- KUOGVAQYJVTWCH-UHFFFAOYSA-N N-[(5-chloro-7-pyridin-4-yl-2,3-dihydro-1-benzofuran-2-yl)methyl]acetamide Chemical compound CC(=O)NCC1Cc2cc(Cl)cc(c2O1)-c1ccncc1 KUOGVAQYJVTWCH-UHFFFAOYSA-N 0.000 description 1
- 229910004616 Na2MoO4.2H2 O Inorganic materials 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 102100036478 Trafficking protein particle complex subunit 14 Human genes 0.000 description 1
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010352 biotechnological method Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- XVVLAOSRANDVDB-UHFFFAOYSA-N formic acid Chemical compound OC=O.OC=O XVVLAOSRANDVDB-UHFFFAOYSA-N 0.000 description 1
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- RSASMEONNPBNKR-UHFFFAOYSA-N n-[3-(4-aminoquinazolin-6-yl)-5-fluorophenyl]-3-(dimethylamino)propanamide Chemical compound CN(C)CCC(=O)NC1=CC(F)=CC(C=2C=C3C(N)=NC=NC3=CC=2)=C1 RSASMEONNPBNKR-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000000888 organogenic effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- FDEIWTXVNPKYDL-UHFFFAOYSA-N sodium molybdate dihydrate Chemical compound O.O.[Na+].[Na+].[O-][Mo]([O-])(=O)=O FDEIWTXVNPKYDL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/42—Geraniaceae, e.g. Geranium
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/02—Flowers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
Definitions
- the invention provides a new distinct somaclone of rose scented geranium P. graveolens christened as ‘Parimal’ characterized by distinct morphology and improved oil yield determining parameters.
- the said novel somaclone has been developed from callus through in vitro tissue culture technique, without enforced mutagenesis.
- the plant possesses characteristic leaf morphology, vigorous growth, improved oil content per plant, herb yield and oil yield.
- the oil produced by this somaclone resembles the oil produced by the commercial type of bourbon geranium oil in that has equivalent ratio of citronellol and geraniol.
- the present invention relates to a new and distinct somaclone of rose scented geranium Pelargonium graveolens a member of the family Geraniaceae, which is a stable somaclone of the Indian cultivar Hemanti.
- the oil of geranium finds extensive use in perfumery, cosmetics, food and pharmaceutical industries (Narayana, 1986). Geranium was introduced in India in the beginning of this century and since then its cultivation and production of oil remained restricted to the high altitude regions of Ootacamund, Kodaikanal and Yercaud areas in South India (Narayana, 1986). India produces hardly 5 tonnes of geranium oil annually as against its own requirement of approximate 100 tonnes per year (Narayana 1986). The production of oil has declined gradually over the years and much of the requirement is met by imports. This may be due to narrow genetic base, resulting partially from sexual infertility, vegetative mode of propagation and restricted area of cultivation.
- the main objective of the inventin is to develop useful somaclonal variants of rose scented geranium christened as ‘Parimal ’which are distinct, stable and uniform through successive generations.
- Another object is to develop somaclonal variants yielding high quality and quantity of essential oil.
- the present invention provides a novel variety of rose scented geranium called ‘Parimal ’said plant developed through in vitro tissue culture methods from callus cultures.
- the invention further provides a useful somaclonal variant ‘Parimal’ of rose scented geranium ( Pelargonium graveolens cv. Hemanti) yielding high quality and quantity of essential oil.
- the invention provides a novel somaclone of rose scented geranium called ‘Parimal’.
- the said plant has been developed though in vitro tissue cultured on modified Murashige and Skoog's medium (MS), 1962 .
- the invention further provides a useful somaclonal variant ‘Parimal’ of rose scented geranium ( Pelargonium graveolens cv. Hemanti) having the following morphological characteristics.
- This invention further provides the useful somaclonal variant “Parimal” of rose scented geranium ( P. graveolens cv. Hemanti) having the following essential oil quality determining characteristics.
- the average and mean percentage of the respective constituents of the essential oil are provided hereinbelow:
- This invention further provides the said somaclone “Parimal” which exhibited uniqueness with respect to the following RAPD primers:MAP-05, MAP-12, MAP-15 and MAP-16.
- FIG. 1 Field grown plant of somaclone “Parimal” having large round canopy and profuse branching.
- FIG. 2 Field grown plant of wild type parent spreading prostrate canopy and comparatively less branching.
- FIG. 3 Leaves of somaclone “Parimal” and wild type showing comparatively less dentation in the leaf of the former than that in the latter.
- the rooted plants were initially hardened under glass house conditions and were subsequently transferred to the field in the month of October 1996, in replicated trials. Based on the superior performance for vigorous growth resulting from extensive branching and enlarged canopy size, comparatively better oil yield over that of the control wild type cultivar and distinctively improved oil quality in terms of the major terpenoid constituents, the plant of this invention (Somaclone “Parimal”) was selected for further observation and evaluations. During the monsoon seasons of 1996-97, this selected somaclone along with control parent were maintained under glass-house conditions through stem-cuttings which also maintained clonal purity.
- the selected clone “Parimal” was grown in field in replicated trials along with its parent Hemanti cultivar for two consecutive winter-summer seasons of 1997-98 and 1998-99, while during the intermediate monsoon season, they were maintained under glass-house conditions.
- the clone “Parimal” maintained its vigorous growth through extensive branching, better oil content and improved oil quality over the three consecutive years.
- the characteristics of this particular clone (in terms essential oil quantity and quality determining traits) in relation to that of the control parent and other clones have been represented in Tables-2 and 3.
- somaclone “Parimal” No variants has been recovered during multiplication, maintenance and testing of the somaclone “Parimal” in experimental plots, screened carefully in 1996-97, 1997-98 and 1998-99 winter-summer cropping seasons.
- the three year's observations on somaclone “Parimal” were statistically analysed for significance of differences in the morphological oil yield determining attributes and the concentrations of 9 geranium oil quality determining terpenoid constituents.
- the intraclonal variation in clone “Parimal” was found statistically insignificant over three year's field trial.
- the somaclones “Parimal” are distinct in having large round canopy, less dentated round leaf morphology, extensive branching and absence of flowering (Table 1). Its oil profile is distinct from the wild type parent cultivar in having higher proportion of geraniol and lower proportion of citronellol, lower content of cis+trans rose oxide and citronellyl formate, 6,9-guadiene, higher content of linalool, geranyl formate and 10-epi-y endesmol (Table-2). Its RAPD profile was different from the wild type parent in certain aspects while had certain features common in both.
- MAP primers MAP 04, MAP 05, MAP 10, MAP 14, MAP 15, MAP 16
- Table 4 gives the similarity index between the two genotypes in paired test.
- somaclone “Parimal” and wild type parent are genetically distinguishable (Table 4).
- the primer MAP 10, MAP 14 showed least similarity while primers MAP 04 and MAP15 showed close relatedness.
- the primers MAP05 and MAP16 showed intermediate degree of similarity.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physiology (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Environmental Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
A new and distinct somaclone of rose scented geranium Pelargonium graveolens christened ‘Parimal’ characterized by distinct morphology and improved oil yield determining parameters.
Description
The invention provides a new distinct somaclone of rose scented geranium P. graveolens christened as ‘Parimal’ characterized by distinct morphology and improved oil yield determining parameters. The said novel somaclone has been developed from callus through in vitro tissue culture technique, without enforced mutagenesis. The plant possesses characteristic leaf morphology, vigorous growth, improved oil content per plant, herb yield and oil yield. The oil produced by this somaclone resembles the oil produced by the commercial type of bourbon geranium oil in that has equivalent ratio of citronellol and geraniol.
The present invention relates to a new and distinct somaclone of rose scented geranium Pelargonium graveolens a member of the family Geraniaceae, which is a stable somaclone of the Indian cultivar Hemanti. The oil of geranium finds extensive use in perfumery, cosmetics, food and pharmaceutical industries (Narayana, 1986). Geranium was introduced in India in the beginning of this century and since then its cultivation and production of oil remained restricted to the high altitude regions of Ootacamund, Kodaikanal and Yercaud areas in South India (Narayana, 1986). India produces hardly 5 tonnes of geranium oil annually as against its own requirement of approximate 100 tonnes per year (Narayana 1986). The production of oil has declined gradually over the years and much of the requirement is met by imports. This may be due to narrow genetic base, resulting partially from sexual infertility, vegetative mode of propagation and restricted area of cultivation.
In India, two cultivars of geranium are mainly known; these are the types that produce Algerian or Tunisian quality and the Bourbon or the Reunion quality of geranium oils; these are given the names Pelargonium×graveolens cv Hemanti and Pelargonium×graveolens cv Bipuli, respectively. The cultivar Hemanti was found to be more adaptive than the cultivar Bipuli both in the hilly regions as well as in the unconventional areas of the plains. On the other hand, the cultivar Bipuli scored better than the Hemanti mainly because of its better oil yield and improved organoleptic value of the oil. The perfumery value of geranium oil is mainly determined by the ratio of citronellol and geraniol and almost equal contents of these two major terpenoid components is generally considered to be the characteristic of the best quality geranium oil.
In an attempt to extend the area of cultivation of geranium to the Indo-gangetic plains, the better adaptive Hemanti cultivar was introduced in the Lucknow conditions in India. Subsequently, efforts were made through different biotechnological methods to develop clones with high content and desirable composition of the oil. The calliclone ‘Parimal ’evolved through this invention represents improvement over the wild type Hemanti parental cultivar both in terms of quality and quantity determining traits of the essential oil. This particular somaclone, being consistently conditions, can offer an improved cultivar for commercial exploitation.
The main objective of the inventin is to develop useful somaclonal variants of rose scented geranium christened as ‘Parimal ’which are distinct, stable and uniform through successive generations.
Another object is to develop somaclonal variants yielding high quality and quantity of essential oil.
Accordingly the present invention provides a novel variety of rose scented geranium called ‘Parimal ’said plant developed through in vitro tissue culture methods from callus cultures. The invention further provides a useful somaclonal variant ‘Parimal’of rose scented geranium (Pelargonium graveolens cv. Hemanti) yielding high quality and quantity of essential oil.
In accordance with the above and other objects, the invention provides a novel somaclone of rose scented geranium called ‘Parimal’. The said plant has been developed though in vitro tissue cultured on modified Murashige and Skoog's medium (MS), 1962.
The invention further provides a useful somaclonal variant ‘Parimal’ of rose scented geranium (Pelargonium graveolens cv. Hemanti) having the following morphological characteristics.
- Parentage: Pelargonium graveolens cultivar Hemanti.
- Propagation: Exclusively vegetative propograted through terminal stem cuttings.
- Time to initiate roots: 15-20 days.
- Time to produce a rooted young plant through terminal stem cuttings: 30-35 days.
- Terminal stem cuttings: 30-35 days.
- Root description: Fibrous, brown in color.
- Rooting habit: Freely branching, dense.
- Plant description:
-
- General appearance.—Upright, with larger and dense spreading canopy.
- Growth branching habit.—Vigorous, showing extensive basal tillering.
- Plant length.—85-95 cm.
- Growth habit. —Spreading, round canopy.
- Plant height, to top of foliar plane.—˜46 cm.
- Stem.—Green, internodes 8-9 cms long, nodes pinkish
- Main branches.—Length about 85 cm. diameter about 1.1 cm internode length about 4 cm. texture pubescent, color 138D, color at nodes 75C.
- Lateral branches.—Length about 70 cm. diameter about 0.7 cm, intermode length about 8 cm. texture pubescent, color 138D.
- Leaves.—Number per branch 25. Arrangement Alternate. Length ˜6 cm. Width ˜5 cm. Texture pubescent. Shape thick, serrated with round lobes. Apex obtuse. Base cordate. Number of Primary lobes 3. Secondary lobes 12-15. Tip Blunt. Leaf area 20-28 cm2. Texture (upper surface) pubescent. Texture (lower surface) pubescent. Petiole ˜8 cm (pinkish). Morphological marker Less dentated leaf morphotype (Ldl). Leaf/stem ratio (L/S) 2.1. Herb yield/plant 4.5 kgs. % oil content 0.18 (mean). Oil yield /plant 7.1 gms. (mean). Oil yield (kg/ha) 71.1 (mean).
- Flower.—No flowering entire lifetime.
- Seed.—No seed formation.
-
- Disease Resistance: Exhibited no specific susceptibility towards the commonly occurring fungus.
This invention further provides the useful somaclonal variant “Parimal” of rose scented geranium (P. graveolens cv. Hemanti) having the following essential oil quality determining characteristics. The average and mean percentage of the respective constituents of the essential oil are provided hereinbelow:
| Essential oil constituents | Percentage (%) | ||
| Linalool | 9.1 | ||
| Cis + Trans rose oxide | 0.60 | ||
| Menthone | 0.2 | ||
| Isomenthone | 7.8 | ||
| Citronellol | 27.6 | ||
| Geraniol | 22.6 | ||
| Citronellyl formate | 5.9 | ||
| Geranyl formate | 2.1 | ||
| Citronellyl acetate | 0.2 | ||
| β-caryophyllene | 0.2 | ||
| 6,9 guaiadiene | 0.6 | ||
| citronellyl butyrate | 1.0 | ||
| 10 Epi-γ-eudesmo | 7.3 | ||
| Citronellyl tiglate | 0.8 | ||
This invention further provides the said somaclone “Parimal” which exhibited uniqueness with respect to the following RAPD primers:MAP-05, MAP-12, MAP-15 and MAP-16.
The methods and examples for the development of the said novel plant “Parimal” are provided herein below, for illustration of the invention and should not be construed as limitations on the concept of the invention. Modifications that may be apparent to those skilled in the art are deemed to fall within the scope of the present invention.
The invention is further illustrated with reference to the following drawings wherein:
FIG. (a-d): Variation in the RAPD profiles of wild type parent (C) with that of the selected somaclone “Parimal” (marked with (→)arrow); a:primer MAP-5; b:primer MAP-12; c:primer MAP-15; d: primer MAP-16.
Methods for development of the novel somaclonal variant “Parimal”:
Healthy robust shoots, raised by subculturing the organogenic calli on modified MS medium with concentrations of BAP and NAA, were transferred to half strength MS medium with a concentration of indole butyric acid (UBA) for rhizogenesis. The stem explants were cultured on modified Murashige and Skoog's medium (MS), 1962 containing the following (in mg/L)-NH4NO3 (1650), KNO3 (1900), CaCl2.2H2O (400), MgSO4.7H2O (370), KH2PO4 (170), Na2EDTA.2H2O (7.2), FeSO4.7H2O (27.8), MnSO4.4H2O (22.3), ZnSO4.7H2O (8.6), H3BO3 (6.2), KI (0.83), Na2MoO4.2H2O (0.25), CuSO4.5H2O (0.025), CoCl2.6H2O (0.025), Glycine (2.0), Nicotinic acid (0.5), Pyrodoxine HCl (0.5) and Thiamine HCl (0.1) with proportion of naphthelene acetic acid (NAA) and Kinetin (Kn)[2:1]. The best organogenesis (85%) could be achieved by substituting Kinetin with 6-Benzylaminopurine (BAP).
The rooted plants were initially hardened under glass house conditions and were subsequently transferred to the field in the month of October 1996, in replicated trials. Based on the superior performance for vigorous growth resulting from extensive branching and enlarged canopy size, comparatively better oil yield over that of the control wild type cultivar and distinctively improved oil quality in terms of the major terpenoid constituents, the plant of this invention (Somaclone “Parimal”) was selected for further observation and evaluations. During the monsoon seasons of 1996-97, this selected somaclone along with control parent were maintained under glass-house conditions through stem-cuttings which also maintained clonal purity. The selected clone “Parimal” was grown in field in replicated trials along with its parent Hemanti cultivar for two consecutive winter-summer seasons of 1997-98 and 1998-99, while during the intermediate monsoon season, they were maintained under glass-house conditions. The clone “Parimal” maintained its vigorous growth through extensive branching, better oil content and improved oil quality over the three consecutive years. The characteristics of this particular clone (in terms essential oil quantity and quality determining traits) in relation to that of the control parent and other clones have been represented in Tables-2 and 3. The results clearly demonstrate the outstanding performance of clone “Parimal” over that of the control wild type parent and other selected clones under Lucknow field conditions, indicating the feasibility of its commercial cultivation in the indo-gangetic plains. It is pertinent to mention ere that the oil profile of somaclone “Parimal” is superior than that of the wild type parent in having equal content of citronellol and geraniol which is a critical characteristic of best quality commercial geranium oil. The field grown plant of “Parimal” having large round canopy is shown in FIG. 1 and FIG. 2 depicts the wild type parent. The leaves of “Parimal” are as shown in FIG. 3.
Evidences of uniformity and stability
The somaclone “Parimal” has remained stable and uniform for its morphological characters and showed consistency in performance for various oil yield and quality determining attributes during its field evaluation under Lucknow conditions over three consecutive years of 1996-97, 1997-98 and 1998-99 are depicted in (Tables 1-3).
Morphological description of the somaclone “Parimal” and its wild type parent
-
- 1) Genus — Pelargonium
- 2) Species — graveolens
- 3) Family — Geraniaceae
- 4) Common name — rose-scented geranium
| TABLE 1 |
| Comparative analysis of oil yield and quality determining traits in the |
| field grown morphologically distinct somaclones, “Parimal” and |
| wild type Pelargonium graveolens CV. Hemanti (control). |
| Soma- | % contents of major terpenoids | |
| clone | Oil | in the essential oil of geranium |
| desig- | Morpho- | yield/ | Cis + trans | |
| nation | types | plant (g) | Linalool | rose oxide |
| A | Highly | 4.5 ± 0.5 | 1.1 ± 0.2 | 1.6 ± 0.4 |
| B | dentated | 3.3 ± 0.7 | 1.1 ± 0.2 | 1.3 ± 0.3 |
| C | leaf | 8.6 ± 3.7 | 0.9 ± 0.1 | 1.2 ± 0.2 |
| D | 4.6 ± 1.2 | 1.0 ± 0.3 | 0.9 ± 0.3 | |
| Parimal | Less | 11.3 ± 2.8 | 9.1 ± 1.6 | 0.6 ± 0.12 |
| dentated | ||||
| leaf | ||||
| L | Less | 8.0 ± 4.0 | 8.5 ± 2.8 | 0.6 ± 0.1 |
| M | dentated | 4.5 ± 0.8 | 7.8 ± 1.5 | 0.7 ± 0.2 |
| N | leaf | 5.1 ± 1.6 | 7.5 ± 1.3 | 0.6 ± 0.2 |
| W | Highly | 3.8 ± 0.33 | 0.7 ± 0.1 | 1.5 ± 0.3 |
| (control) | dentated | |||
| Soma- | ||
| clone | % contents of major terpenoids | |
| desig- | Morpho- | in the essential oil of geranium |
| nation | types | Isomenthone | Citronellol | Geraniol |
| A | Highly | 9.6 ± 1.8 | 49.8 ± 1.4 | 2.0 ± 0.5 |
| B | dentated | 9.0 ± 2.5 | 52.6 ± 1.9 | 2.3 ± 0.6 |
| C | leaf | 10.3 ± 1.3 | 51.7 ± 1.1 | 1.8 ± 0.4 |
| D | 10.6 ± 2.1 | 48.6 ± 4.5 | 2.3 ± 1.1 | |
| Parimal | Less | 7.8 ± 0.53 | 27.6 ± 2.1 | 22.6 ± 3.2 |
| dentated | ||||
| leaf | ||||
| L | Less | 7.7 ± 0.5 | 28.7 ± 4.3 | 22.3 ± 2.8 |
| M | dentated | 6.9 ± 1.5 | 29.2 ± 3.9 | 20.4 ± 2.1 |
| N | leaf | 7.1 ± 1.2 | 29.1 ± 4.4 | 19.5 ± 3.1 |
| W | Highly | 9.5 ± 0.1 | 53.1 ± 0.7 | 1.6 ± 0.14 |
| (control) | dentated | |||
| % contents of major terpenoids | |
| Soma- | in the essential oil of geranium |
| clone | Citronel- | ||||
| desig- | Morpho- | llyl | Geranyl | 6,9- | 10-epi-□- |
| nation | types | formate | formate | guaiadiene | eudesmol |
| A | Highly | 13.0 ± 0.4 | 0.5 ± 0.3 | 1.3 ± 0.6 | 2.9 ± 0.5 |
| B | dentated | 11.7 ± 1.3 | 0.3 ± 0.15 | 1.3 ± 0.4 | 3.0 ± 0.7 |
| C | leaf | 11.1 ± 0.9 | 0.23 ± 0.03 | 1.3 ± 0.4 | 2.9 ± 0.5 |
| D | 10.2 ± 2.7 | 0.6 ± 0.45 | 1.2 ± 0.4 | 4.4 ± 1.4 | |
| Parimal | Less | 5.9 ± 0.2 | 2.1 ± 0.4 | 0.6 ± 0.12 | 7.3 ± 0.95 |
| dentated | |||||
| leaf | |||||
| L | Less | 5.6 ± 0.7 | 2.0 ± 0.2 | 0.7 ± 0.1 | 7.4 ± 1.1 |
| M | dentated | 4.8 ± 0.7 | 1.8 ± 0.2 | 0.7 ± 0.03 | 8.6 ± 1.8 |
| N | leaf | 4.7 ± 0.8 | 1.8 ± 0.6 | 0.6 ± 0.05 | 8.2 ± 1.6 |
| W | Highly | 12.1 ± 0.6 | 0.23 ± 0.03 | 2.0 ± 0.2 | 3.2 ± 0.2 |
| (control) | dentated | ||||
| TABLE 2 |
| Morphological characteristics of |
| somaclone “Parimal” and its wild type parent |
| Morphological | ||
| parameters | Parimal | Wild type |
| Plant height | 85-95 cm | 35-45 cm |
| Growth habit | spreading, round canopy | Spreading prostrate |
| Stem | green, internodes | Greenish magenta |
| 8-9 cms long, | purplish at the nodes, | |
| nodes pinkish | 5-10 mm in diameter, | |
| densely hairy | ||
| Branches | 91-101 | 10-45 |
| Leaf | ||
| Number per branch | 10-25 | 25-30 |
| Texture | pubescent | pubescent |
| Shape | thick, serrated with round | thick hairy highly |
| lobes | serrated | |
| Number of | ||
| primary lobes | 3 to 5 | |
| secondary lobes | 3 | 15-30 |
| 12-15 | ||
| Tip | Blunt | Blunt |
| Leaf area | 20-28 cm2 | 30-36 cm2 |
| Petiole | ˜8 cm (pinkish) | ˜5 cm (green) |
| TABLE 3 |
| Oil yield and quality determining traits of somaclone “Parimal” and |
| its wild type parent. |
| Somaclone | ||||
| Trait | “Parimal” | Wild type | ||
| 1. | Morphological marker | Less dentated | Highly dentated leaf |
| leaf morphotype | morphotype (Hdl) | ||
| (Ldl) | |||
| 2. | Leaf/stem ratio (L/S) | 2.1 | 1.5 |
| 3. | Herb yield/plant | 4.5 kgs. | 1.9 kgs |
| 4. | % oil content | 0.18 | 0.15 |
| 5. | Oil yield/plant | 7.1 gms. | 2.5 gms. |
| 6. | Oil yield (kg/ha) | 71.1 | 25.1 |
| 7. | Oil quality | ||
| i) | Linalool | 9.1 | 0.7 |
| ii) | Cis + Trans rose | 0.60 | 1.5 |
| oxide | |||
| iii) | Menthone | 0.2 | 0.3 |
| iv) | Isomenthone | 7.8 | 9.5 |
| v) | Citronellol | 27.6 | 53.1 |
| vi) | Geraniol | 22.6 | 1.6 |
| vii) | Citronellyl formate | 5.9 | 12.1 |
| viii) | Geranyl formate | 2.1 | 0.2 |
| ix) | Citronellyl acetate | 0.2 | 0.9 |
| x) | β-caryophyllene | 0.2 | 1.5 |
| xi) | 6,9 guaiadiene | 0.6 | 2.0 |
| xii) | citronellyl butyrate | 1.0 | 2.2 |
| xiii) | 10 Epi-γ-eudesmol | 7.3 | 3.2 |
| xiv) | Citronellyl tiglate | 0.8 | 1.6 |
Type and frequency of variants during multiplication and maintenance of the somaclone
No variants has been recovered during multiplication, maintenance and testing of the somaclone “Parimal” in experimental plots, screened carefully in 1996-97, 1997-98 and 1998-99 winter-summer cropping seasons. The three year's observations on somaclone “Parimal” were statistically analysed for significance of differences in the morphological oil yield determining attributes and the concentrations of 9 geranium oil quality determining terpenoid constituents. The intraclonal variation in clone “Parimal” was found statistically insignificant over three year's field trial.
Statement of distinction
The somaclones “Parimal” are distinct in having large round canopy, less dentated round leaf morphology, extensive branching and absence of flowering (Table 1). Its oil profile is distinct from the wild type parent cultivar in having higher proportion of geraniol and lower proportion of citronellol, lower content of cis+trans rose oxide and citronellyl formate, 6,9-guadiene, higher content of linalool, geranyl formate and 10-epi-y endesmol (Table-2). Its RAPD profile was different from the wild type parent in certain aspects while had certain features common in both.
Characterization through RAPD markers
Using 13 random primers (MAP 01 to MAP 16) with following sequence description a comparison was made for somaclone “Parimal” and its wild type parent to establish the relatedness between them.
| Primer | Base Sequence |
| MAP01 | GTGCAATCAG SEQ. ID NO: 1 |
| MAP02 | AGGATACGTG SEQ. ID NO: 2 |
| MAP04 | AAGATAGCGG SEQ. ID NO: 3 |
| MAP05 | GGATCTGAAC SEQ. ID NO: 4 |
| MAP06 | TTGTCTCAGG SEQ. ID NO: 5 |
| MAP07 | GTCCTACTCG SEQ. ID NO: 6 |
| MAP09 | TGCGCGATCG SEQ. ID NO: 7 |
| MAP10 | AACGTACGCG SEQ. ID NO: 8 |
| MAP11 | GCACGCCGGA SEQ. ID NO: 9 |
| MAP12 | CACCCTGCGC SEQ. ID NO: 10 |
| MAP14 | GGACTCCACG SEQ. ID NO: 11 |
| MAP15 | AAGATAGCGG SEQ. ID NO: 12 |
| MAP16 | CTATCGCCGC SEQ. ID NO: 13 |
This analysis could narrow down with usage of six MAP primers (MAP 04, MAP 05, MAP 10, MAP 14, MAP 15, MAP 16) which in turn were utilized for genotypic pair analysis in order to assess genetic/molecular distances. The following table 4 gives the similarity index between the two genotypes in paired test.
| TABLE 4 |
| Similarity percentage for amplified bands (paired analysis) of |
| somaclone “Parimal” and wild type parent |
| Primer | Genotypic pair (somaclone “Parimal”/wild type) | ||
| MAP 04 | 93 | ||
| MAP 05 | 80 | ||
| MAP 10 | 60 | ||
| MAP 14 | 90 | ||
| MAP 15 | 83 | ||
| MAP 16 | 66 | ||
It is evident from similarity indices (paired test) that somaclone “Parimal” and wild type parent are genetically distinguishable (Table 4). Further, the primer MAP 10, MAP 14 showed least similarity while primers MAP 04 and MAP15 showed close relatedness. The primers MAP05 and MAP16 showed intermediate degree of similarity. These observations on percent similarity confirm the relatedness of somaclone “Parimal” with the wild type parent, at the same time highlight the distinctness of the former at the genetic level. The complete RAPD profile for PCR amplified DNA segments using 12 primers is available providing evidence of distinctiveness of the clone with respect to the control parent as shown in FIG. 4.
Advantages:
-
- 1. “Parimal” is well adaptive to the unconventional area of cultivation i.e. northern Indian plains.
- 2. “Parimal” represents improvement over its wild type parental cv. “Hemanti” with resepect to the following quantitative traits: (a) Larger and denser canopy; (b) Greater herb yield; (c) Higher leaf:stem ratio; (d) Higher oil content; and (e) Much higher oil yield (both on per plant and per hectare basis).
- 3. “Parimal” represent improvement over its wild type parental cv. “Hemanti” with respect to following major essential oil quality determining traits: (a) About equal citronellol:geraniol ratio; (b) Higher rhodinol content; (c) Higher linalool concentration; (d) Lower concentration of 6,9-guaiadiene.
- 4. The somaclone “Parimal” showed consistency in performance for all the above mentioned oil yield and quality determining attributes during its field evaluation under Lucknow conditions over three consecutive years.
- 5. “Parimal” showed distinctiveness even at genetic level with respect to RAPD primers, MAP-05, MAP-12, MAP-15 and MAP-16.
Claims (1)
1. A rose scented Geranium plant named ‘Parimal’, as herein illustrated and described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/539,992 USPP20149P2 (en) | 2000-03-30 | 2000-03-30 | New and distinct somaclonal variety of rose scented geranium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/539,992 USPP20149P2 (en) | 2000-03-30 | 2000-03-30 | New and distinct somaclonal variety of rose scented geranium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USPP20149P2 true USPP20149P2 (en) | 2009-07-07 |
Family
ID=40811178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/539,992 Expired - Lifetime USPP20149P2 (en) | 2000-03-30 | 2000-03-30 | New and distinct somaclonal variety of rose scented geranium |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USPP20149P2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USPP17422P2 (en) * | 2005-06-14 | 2007-02-20 | J.+H. Westhoff Interpel | Geranium plant named ‘Wesvilsu’ |
-
2000
- 2000-03-30 US US09/539,992 patent/USPP20149P2/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USPP17422P2 (en) * | 2005-06-14 | 2007-02-20 | J.+H. Westhoff Interpel | Geranium plant named ‘Wesvilsu’ |
Non-Patent Citations (1)
| Title |
|---|
| MPEP Chapter 1600-Plant Patents; 11 pages. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USPP13720P2 (en) | Mint plant named ‘Aquamint’ | |
| USPP20149P2 (en) | New and distinct somaclonal variety of rose scented geranium | |
| USPP25441P3 (en) | Mint plant ‘Boulder Mint’ | |
| USPP25439P3 (en) | Mint plant ‘Steens Mint’ | |
| USPP25415P3 (en) | Mint plant named ‘Chelan Mint’ | |
| USPP27602P2 (en) | Mint plant ‘Ochoco Mint’ | |
| USPP25108P3 (en) | Mint plant ‘Meadow Mint’ | |
| USPP36034P2 (en) | Coreopisis plant named ‘Golden Needles’ | |
| USPP28363P2 (en) | Mint plant named ‘Jefferson Spearmint’ | |
| USPP29798P3 (en) | Nandina plant named ‘NanSid6’ | |
| USPP25109P3 (en) | Mint plant ‘HooDoo Mint’ | |
| USPP27604P2 (en) | Mint plant ‘Teton Mint’ | |
| USPP27603P2 (en) | Mint plant named ‘Blue Mountain Mint’ | |
| USPP36055P2 (en) | Coreopsis plant named ‘Heartstrings’ | |
| USPP25138P3 (en) | Mint plant ‘Everest Mint’ | |
| USPP17444P3 (en) | Corn plant named ‘Venus Express’ | |
| USPP28673P2 (en) | Mint plant named ‘Klondike’ | |
| USPP29769P3 (en) | Nandina plant named ‘NanSid3’ | |
| KR101624925B1 (en) | White kohlrabi | |
| USPP20761P2 (en) | Lonicera nitida plant named ‘Briliame’ | |
| USPP31754P2 (en) | Achillea plant named ‘Sassy Summer Silver’ | |
| USPP31705P2 (en) | Leucadendron plant named ‘Hawaii Sunrise’ | |
| USPP30968P2 (en) | Artemisia plant named ‘TNARTMS’ | |
| US20220095520P1 (en) | Clematis Plant Named 'Evipo114' | |
| USPP12425P2 (en) | Pelargonium graveolens plant named ‘Narmada’ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: COUNCIL OF SCIENCTIFIC AND INDUSTRIAL RESEARCH, IN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SAXENA, GAURI;BANERJEE, SUCHITRA;RAHMAN, LAIQ UR;AND OTHERS;REEL/FRAME:016787/0775 Effective date: 20000520 |